FDA Approves Jardiance To Treat Adults With Heart Failure
25/2 11:31
(RTTNews) - The U.S. Food and Drug Administration or FDA approved Boehringer Ingelheim's diabetes drug Jardiance (empagliflozin), co developed by Eli Lilly and Co., to mitigate the risk of cardiovascular death and hospitalization for heart failure in adults....